Novel Tool Box For EVs Therapy In Regenerative Medicine
Source: FUJIFILM Wako Chemicals U.S.A. Corp.

Extracellular vesicles (EVs) are small and lipid bilayer particles released by cells. EVs have now been recognized as crucial messengers in intercellular communication via the transfer of bioactive lipids, proteins, and nucleic acids. EVs derived from mesenchymal stem cells (MSC) are emerging as a promising therapeutic strategy in regenerative medicine. Here we introduce our EVs isolation technology - PS affinity method, and the usefulness of it in the regenerative medicine, which we have discovered recently.
access the Application Note!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
FUJIFILM Wako Chemicals U.S.A. Corp.
This website uses cookies to ensure you get the best experience on our website. Learn more